MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*”Architects”: Geriatrics, Gerontology, Geroscience, Longevity, Healthspan & Aging
CALA HEALTH, INC.*
Organization & Developments: Cala Health
Parents
CALA HEALTH, INC.*
Children
*Cala Health has created a watchlike device, the Cala kIQ, that treats hand tremors with transcutaneous afferent patterned stimulation (TAPS) therapy.
*Cala Health’s lead product, Cala Trio™, is the only non-invasive prescription therapy for essential tremor.
*CALA KIQ
*Cala’s kIQ system is worn around the wrist, senses a patient’s tremor signature and personalizes a stimulation pattern to counteract it and delivers the energy non-invasively through the skin.
*New therapies are under development in neurology, cardiology and psychiatry.
*TAPS therapy senses a patient’s tremor patterns and creates a personalized electrical signal pattern that counteracts the tremors.
*The company’s wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation, and its vertically integrated commercial model is reshaping the delivery of prescription therapies.
2022: Cala Health’s Cala Trio is a personalized therapy for essential tremor.
2025: Cala Health Attracts $50 Million in Funding
2026: Cala wins FDA nod for next-gen wearable neurostim tech for essential tremor, Parkinson’s
Jumps
Finance & Acquisition: Cala Health
Key People: Cala Health